ArticleHaematologica2025

LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemia.

Janani Ravikrishnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.